PT3486249T - 99mtc-edda/hynic-ipsma como um radiofármaco para a deteção da hiperexpressão do antigénio da membrana específico da próstata - Google Patents

99mtc-edda/hynic-ipsma como um radiofármaco para a deteção da hiperexpressão do antigénio da membrana específico da próstata

Info

Publication number
PT3486249T
PT3486249T PT178157723T PT17815772T PT3486249T PT 3486249 T PT3486249 T PT 3486249T PT 178157723 T PT178157723 T PT 178157723T PT 17815772 T PT17815772 T PT 17815772T PT 3486249 T PT3486249 T PT 3486249T
Authority
PT
Portugal
Prior art keywords
ipsma
edda
hynic
99mtc
radiopharmaceutical
Prior art date
Application number
PT178157723T
Other languages
English (en)
Original Assignee
Instituto Nac De Investigaciones Nucleares
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto Nac De Investigaciones Nucleares filed Critical Instituto Nac De Investigaciones Nucleares
Publication of PT3486249T publication Critical patent/PT3486249T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
PT178157723T 2016-06-24 2017-06-21 99mtc-edda/hynic-ipsma como um radiofármaco para a deteção da hiperexpressão do antigénio da membrana específico da próstata PT3486249T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016008466A MX2016008466A (es) 2016-06-24 2016-06-24 99mtc-edda/hynic-ipsma como un radiofarmaco para la deteccion de la sobre-expresion del antigeno prostatico de membrana.

Publications (1)

Publication Number Publication Date
PT3486249T true PT3486249T (pt) 2022-02-02

Family

ID=60783979

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178157723T PT3486249T (pt) 2016-06-24 2017-06-21 99mtc-edda/hynic-ipsma como um radiofármaco para a deteção da hiperexpressão do antigénio da membrana específico da próstata

Country Status (15)

Country Link
US (2) US10918745B2 (pt)
EP (2) EP4083049A3 (pt)
CN (1) CN109641924B (pt)
BR (1) BR112018076593B1 (pt)
CA (1) CA3059545C (pt)
DK (1) DK3486249T3 (pt)
EA (1) EA201892668A1 (pt)
ES (1) ES2906332T3 (pt)
HU (1) HUE057891T2 (pt)
MA (1) MA45687A (pt)
MX (1) MX2016008466A (pt)
PL (1) PL3486249T3 (pt)
PT (1) PT3486249T (pt)
WO (1) WO2017222362A1 (pt)
ZA (1) ZA201807828B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018003175A (es) 2018-03-14 2019-09-16 Instituto Nac De Investigaciones Nucleares 177lu-dota-hynic-ipsma como un radiofarmaco terapeutico dirigido al antigeno prostatico especifico de membrana.
PL239934B1 (pl) 2019-04-12 2022-01-31 Narodowe Centrum Badan Jadrowych Osrodek Radioizotopow Polatom Pochodne inhibitorów PSMA do znakowania ⁹⁹ᵐTc poprzez HYNIC, zestaw radiofarmaceutyczny, preparat radiofarmaceutyczny oraz ich zastosowanie w diagnostyce raka prostaty
CN111233758B (zh) * 2020-03-02 2021-04-23 北京大学第一医院 一种psma抑制剂及其应用和靶向psma的核素成像试剂
CN111253465A (zh) * 2020-03-03 2020-06-09 复旦大学附属肿瘤医院 一种psma结合剂及其用途
AU2021258328A1 (en) * 2020-04-24 2022-11-17 Radiomedix, Inc. Composition, kit and method for diagnosis and treatment of prostate cancer
MX2021005089A (es) * 2021-04-30 2022-11-01 Instituto Nac De Investigaciones Nucleares Radiofarmacos basados en el acido ((r)-1-((6-hidrazinilnicotinoil) d-alanil)pirrolidin-2-il)boronico (hynic-ifap) para la deteccion de la sobreexpresion de la proteina de activacion de fibrolastos.
WO2022253785A2 (en) 2021-05-31 2022-12-08 Universität Heidelberg Improved prostate-specific membrane antigen targeting radiopharmaceuticals and uses thereof
WO2023030509A1 (zh) * 2021-09-03 2023-03-09 晶核生物医药科技(南京)有限公司 一种肽脲素衍生物、含其的药物组合物及其应用
CN114569744A (zh) * 2022-03-08 2022-06-03 安徽淮仁堂药业股份有限公司 一种锝前列腺标特异性膜抗原显像剂试剂盒及其制备方法和应用
CN115260155B (zh) * 2022-08-08 2023-11-10 北京师范大学 一种含三唑环和肼基尼古酰胺基的谷氨酸-脲衍生物及其应用
CN117434270B (zh) * 2023-09-11 2024-05-07 江苏省人民医院(南京医科大学第一附属医院) 一种可携带放射性信号的蛋白质支架及其抗体检测中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2921482B1 (en) 2007-06-26 2018-09-05 The Johns Hopkins University Labeled inhibitors of prostate-specific membrane antigen (psma), biological evaluation, and use as imaging agents
MX336322B (es) 2010-04-08 2016-01-12 Inst Nac De Investigaciones Nucleares 99mtc-edda/hynic-ggc-aunp-manosa como un nuevo radiofarmaco para la deteccion del ganglio centinela en cancer de mama.
CN102949735B (zh) 2011-08-30 2015-06-10 北京大基康明医疗设备有限公司 放射性药物的制备方法及系统
CN109125745B (zh) 2012-04-10 2022-07-26 蓝瑟斯医学影像公司 放射性药物合成方法
WO2016062370A1 (en) * 2014-10-20 2016-04-28 Deutsches Krebsforschungszentrum 18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer

Also Published As

Publication number Publication date
US20190343970A1 (en) 2019-11-14
ES2906332T3 (es) 2022-04-18
DK3486249T3 (da) 2022-02-07
EP4083049A2 (en) 2022-11-02
EP3486249A1 (en) 2019-05-22
MA45687A (fr) 2021-03-31
WO2017222362A1 (es) 2017-12-28
HUE057891T2 (hu) 2022-06-28
EP4083049A3 (en) 2022-12-21
US11547767B2 (en) 2023-01-10
CA3059545A1 (en) 2017-12-28
EP3486249B1 (en) 2021-11-10
BR112018076593A2 (pt) 2019-04-16
PL3486249T3 (pl) 2022-05-23
CN109641924B (zh) 2022-02-25
CA3059545C (en) 2021-07-27
BR112018076593B1 (pt) 2022-05-24
US20210187132A1 (en) 2021-06-24
MX2016008466A (es) 2017-12-25
CN109641924A (zh) 2019-04-16
EP3486249A4 (en) 2020-03-11
ZA201807828B (en) 2021-03-31
US10918745B2 (en) 2021-02-16
EA201892668A1 (ru) 2019-10-31

Similar Documents

Publication Publication Date Title
HUE057891T2 (hu) 99MTC-EDDA/HYNIC-IPSMA mint radiofarmakon a prosztataspecifikus membrán antigén túlzott expressziójának kimutatására
SG11201605580RA (en) Antibodies directed against interleukin-33 (il-33)
GB201511191D0 (en) T-cell epitopes for the immunotherapy of myeloma
EP3256454A4 (en) Integrated methods for chemical synthesis
EP3148959A4 (en) Integrated methods for chemical synthesis
GB201418899D0 (en) System for radiopharmaceutical production
SG11201607030PA (en) Antibodies, uses & methods
IL281292A (en) Processes for preparing a diarylthiohydantoin compound
IL264187B (en) Radioligands for imaging of ido1 enzymatic radioligands for imaging of ido1 enzyme
EP3512537C0 (en) T-CELL IMMUNOTHERAPY
IL265805A (en) Arginase immunogenic peptides
IL247988A0 (en) Antibodies against hpa–1a
HK1250034A1 (zh) 新型抗-pcsk9抗體
PL3325941T3 (pl) Układ do określania szybkości przenikania przez próbkę
GB201419457D0 (en) Undersea sensing system
HK1249538A1 (zh) 新型抗-pcsk9抗體
IL249076A0 (en) A system for expanding the size of a balcony
GB201617003D0 (en) Sensor retention
AU2016903575A0 (en) Modified Immunogen
AU5383P (en) Blondie Phormium cookianum
GB201413950D0 (en) Antibodies, uses & methods
GB201400597D0 (en) Antibodies, uses & methods